GluN2A(D731N) reduces the agonist potency. by Kai Gao (120150)

“…<p>(<b>A,B</b>) Representative TEVC recordings obtained from oocytes expressing WT GluN1/GluN2A (WT 2A) receptors (<b>A</b>) and GluN1/GluN2A(D731N) (2A-D731N) receptors (<b>B</b>) in which the currents were evoked by increasing concentrations (μM) of glutamate (in the presence of 100 μM glycine) at the holding potential of -40 mV. …”

Decreased type 1 IFN and enhanced MHV-68 loads in lungs of TLR2- and MyD88-deficient mice. by François Michaud (360245)

Antibody responses and FRT pathology are comparable between WT and <i>Bhlhe40</i>^<i>-/-</i> mice. by Miguel A. B. Mercado (17847533)

Decreased cell integrity and an increased number of intracellular membrane compartments in <i>ap1b1</i> mutant HCs. by Rachel Clemens Grisham (402043)

Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio by Jani Luukkonen (4339744)

“…The TRAcP 5B/5A ratio was decreased in RA and correlated negatively with the amount of phospho-OPN (p<0.05). …”

Loss of SRC-2 results in decreased expression of several cardiac transcription factors important for controlling metabolic and sarcomeric gene expression. by Erin L. Reineke (107382)

LS-PGC-1β^−/− mice exhibit decreased expression of TCA and ETC enzymes and mtDNA content. by Kari T. Chambers (106919)

Enhanced Nrf2 activity decreases fatty acid transport and results in increased fatty acids content in white adipose tissue. by Jialin Xu (40952)

APB5, but not APA5, decreases apoptosis in alveolar epithelial cells in lungs of BLM-treated mice. by Masami Kishi (6167105)

“…The administration of APA5 did not change the number of TUNEL-positive cells from that in BLM-treated mice, whereas that of APB5 significantly decreased them. …”

S1/2^-/- mice display novelty induced hyperactivity, decreased anxiety and exploratory behavior and working memory disturbances. by Paul C. Baier (650225)

“…WT: n = 24, S1/2^-/-: n = 26. A) Novelty-induced hyperactivity in S1/2^-/- mice as assessed by moving distance in the open field (p_MW = 0.0006). …”

Magnitude-breadth of linear V2 hotspot binding response. by LaTonya D. Williams (3140490)

Identification of small molecules that inhibit viral M mRNA nuclear export and/or decrease viral M mRNA levels. by Matthew Esparza (8661219)

“…To better visualize the distribution of compounds within the desired range (Z-score < -3), the Z-score range of the graph has been focused to view data points that show decrease in viral M mRNA fluorescence.…”

Impaired glucose metabolism and decreased insulin sensitivity in isolated adipocytes of Nscl-2−/−, Nscl-2−/−×ob/ob mice and controls. by Karen Ruschke (372824)

Delayed boosting with ALVAC-HIV/AIDSVAX B/E or AIDSVAX B/E increases V1V2-specific IgG concentration and breadth. by LaTonya D. Williams (3140490)

HC-070 decreases anxiety after CCK-4 treatment in an EPM. by Stefan Just (4811358)

Figure S1 - VILIP-1 Expression <em>In Vivo</em> Results in Decreased Mouse Skin Keratinocyte Proliferation and Tumor Development by Jian Fu (41067)

Treatment with vitamin D3 reduced the viability of cancer cell lines: <i>1A & 1B.</i> by Vidya G. Bettada (22208808)

“…Cytotoxicity assays were carried out atleast 2 times with 3 replicate measurements in each experiment. The bars represent the average of three independent experiments with the significance (P) determined by One-Way ANOVA at each time point. …”

Data. by Rim Kooli (15426816)

Subjects:

Semen characteristics in the study population. by Rim Kooli (15426816)

Subjects:

Decreased phosphorylation of GSK3β-Ser9 in thrombin stimulated PP1cγ^−/− platelets. by Francisca C. Gushiken (368549)

“…Data are expressed as ±SEM of 5 experiments. (<b>D</b>) Effect of GSK3β inhibitor VIII on thrombin-induced fibrinogen binding on WT and PP1cγ^−/− platelets. …”